Identification of oxidative stress signatures of lung adenocarcinoma and prediction of patient prognosis or treatment response with single-cell RNA sequencing and bulk RNA sequencing data
-
Published:2024-08
Issue:
Volume:137
Page:112495
-
ISSN:1567-5769
-
Container-title:International Immunopharmacology
-
language:en
-
Short-container-title:International Immunopharmacology
Author:
Yu Yunchi,
Liu Miaoyan,
Wang Zihang,
Liu Yufan,
Yao Min,
Wang Li,
Zhong LouORCID
Reference76 articles.
1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021
2. Cancer statistics in China and United States, 2022: profiles, trends, and determinants;Xia;Chin. Med. J. (Engl).,2022
3. Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment;Duma;Mayo Clin. Proc.,2019
4. Second-line therapy of squamous non-small cell lung cancer: an evolving landscape;Lazzari;Expert. Rev. Respir. Med.,2017
5. 2nd ESMO Consensus Conference on Lung Cancer: Early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up;Vansteenkiste;Ann. Oncol.,2014